SCHEMBL7420833

SCHEMBL7420833

N#CC1(N(Cc2ccccc2)C(=O)C(C(N)=O)C2CCCCC2)CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
EPHX1 P07099 4/20 0.37
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ATM Q13315 2/20 0.33
GHSR Q92847 1/20 0.33
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
MAPK1 P28482 1/20 0.32
CTSS P25774 2/20 0.32
CTSK P43235 1/20 0.32
EPHX2 P34913 1/20 0.32
ADRA1D P25100 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6371524 0.94 L3MBTL1 (0.40) L3MBTL1EPHX1MEN1KMT2AALDH1A1
SCHEMBL7014390 0.90 L3MBTL1 (0.43) L3MBTL1EPHX1MEN1KMT2AALDH1A1
SCHEMBL7417235 0.75 L3MBTL1 (0.35) L3MBTL1EPHX1MEN1KMT2AALDH1A1
SCHEMBL7419196 0.75 EPHX1 (0.32) EPHX1
SCHEMBL7414878 0.75 BACE1 (0.41) MEN1KMT2AALDH1A1HTTCTSS
SCHEMBL7420829 0.72 SNCA (0.34) ALDH1A1MAPK1CTSSCTSK
SCHEMBL7419141 0.72 AGER (0.39) HTTNPSR1
SCHEMBL7415546 0.72 PSEN1 (0.34) ALDH1A1KDM4EGHSRCTSSCTSK
SCHEMBL7414874 0.71 CTSS (0.46) CTSSCTSK
SCHEMBL7417228 0.70 CTSL (0.44) ATMCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed